Compugen Ltd
NASDAQ:CGEN
Compugen Ltd
NASDAQ:CGEN
Price:
1.8903 USD
-0.51%
Updated:
Apr 18, 2024
Compugen Ltd
Revenue
Last
Value
3-Years CAGR
5-Years CAGR
|
Compugen Ltd
Revenue Peer Comparison
Comparables:
Q
QNRX
B
BOLT
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Compugen Ltd
NASDAQ:CGEN
|
Revenue
$33.5m
|
CAGR 3-Years
156%
|
CAGR 5-Years
13%
|
CAGR 10-Years
26%
|
|
Q
|
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
|
Revenue
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
B
|
Biolight Life Sciences Ltd
TASE:BOLT
|
Revenue
₪118k
|
CAGR 3-Years
56%
|
CAGR 5-Years
-50%
|
CAGR 10-Years
4%
|
Compugen Ltd
Revenue Breakdown
Breakdown by Geography
Compugen Ltd
Compugen Ltd
|
Total Revenue:
33.5m
USD
|
|
Unites States:
23.5m
USD
|
|
Europe:
10m
USD
|
Breakdown by Segments
Compugen Ltd
Compugen Ltd
Not Available
See Also
What is Compugen Ltd's Revenue?
Revenue
33.5m
USD
33.5m
USD
Based on the financial report for Dec 31, 2023, Compugen Ltd's Revenue amounts to 33.5m USD.
What is Compugen Ltd's Revenue growth rate?
Revenue CAGR 10Y
26%
26%
Over the last year, the Revenue growth was 346%. The average annual Revenue growth rates for Compugen Ltd have been 156% over the past three years , 13% over the past five years , and 26% over the past ten years .
You don't have any saved screeners yet
